Figure 3.

An example progression of patient on placebo. Overview of quantitation at two encounters of a patient on placebo: 72-year-old Asian female, baseline serum EPA 29.5, decreasing to 21.9 at 9 months. The 3D view of RCA, LAD, and LCX, with corner annotations for left coronary. The baseline values for LRNC volume (shown in yellow), minimum cap thickness, maximum wall thickness, and IPH volume (shown in rust) are 132 mm³, 348 μm, 3.3 mm, and 26 mm³, respectively. At follow-up, LRNC increased to 259 mm³, IPH to 50 mm³, cap thickness decreased to 167 μm, and wall thickness increased to 3.6 mm. The presentation of LRNC indicates coalescing of smaller lipid pools into larger contiguous cores at follow-up in all primary arteries. The 2D cross-section located at cursors in 3D representation shown as insets. Serum EPA values for baseline and follow-up are also shown.